Cargando…

Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States

We estimated direct costs of a 4-month or 6-month regimen for drug-susceptible pulmonary tuberculosis treatment in the United States. Costs were $23,000 per person treated. Actual treatment costs will vary depending on examination and medication charges, as well as expenses associated with directly...

Descripción completa

Detalles Bibliográficos
Autores principales: Winston, Carla A., Marks, Suzanne M., Carr, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521593/
https://www.ncbi.nlm.nih.gov/pubmed/37735769
http://dx.doi.org/10.3201/eid2910.230314
_version_ 1785110163396493312
author Winston, Carla A.
Marks, Suzanne M.
Carr, Wendy
author_facet Winston, Carla A.
Marks, Suzanne M.
Carr, Wendy
author_sort Winston, Carla A.
collection PubMed
description We estimated direct costs of a 4-month or 6-month regimen for drug-susceptible pulmonary tuberculosis treatment in the United States. Costs were $23,000 per person treated. Actual treatment costs will vary depending on examination and medication charges, as well as expenses associated with directly observed therapy.
format Online
Article
Text
id pubmed-10521593
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-105215932023-10-01 Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States Winston, Carla A. Marks, Suzanne M. Carr, Wendy Emerg Infect Dis Dispatch We estimated direct costs of a 4-month or 6-month regimen for drug-susceptible pulmonary tuberculosis treatment in the United States. Costs were $23,000 per person treated. Actual treatment costs will vary depending on examination and medication charges, as well as expenses associated with directly observed therapy. Centers for Disease Control and Prevention 2023-10 /pmc/articles/PMC10521593/ /pubmed/37735769 http://dx.doi.org/10.3201/eid2910.230314 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Winston, Carla A.
Marks, Suzanne M.
Carr, Wendy
Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
title Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
title_full Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
title_fullStr Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
title_full_unstemmed Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
title_short Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
title_sort estimated costs of 4-month pulmonary tuberculosis treatment regimen, united states
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521593/
https://www.ncbi.nlm.nih.gov/pubmed/37735769
http://dx.doi.org/10.3201/eid2910.230314
work_keys_str_mv AT winstoncarlaa estimatedcostsof4monthpulmonarytuberculosistreatmentregimenunitedstates
AT markssuzannem estimatedcostsof4monthpulmonarytuberculosistreatmentregimenunitedstates
AT carrwendy estimatedcostsof4monthpulmonarytuberculosistreatmentregimenunitedstates